436 related articles for article (PubMed ID: 24664935)
21. Treatment with tumor necrosis factor inhibitors in axial spondyloarthritis: comparison between private rheumatology practices and academic centers in a large observational cohort.
Ciurea A; Weber U; Stekhoven D; Scherer A; Tamborrini G; Bernhard J; Toniolo M; Villiger PM; Zufferey P; Kissling RO; Michel BA; Exer P;
J Rheumatol; 2015 Jan; 42(1):101-5. PubMed ID: 25362654
[TBL] [Abstract][Full Text] [Related]
22. Is the current ASAS expert definition of a positive family history useful in identifying axial spondyloarthritis? Results from the SPACE and DESIR cohorts.
Ez-Zaitouni Z; Hilkens A; Gossec L; Berg IJ; Landewé R; Ramonda R; Dougados M; van der Heijde D; van Gaalen F
Arthritis Res Ther; 2017 May; 19(1):118. PubMed ID: 28569222
[TBL] [Abstract][Full Text] [Related]
23. Classification criteria versus physician's opinion for considering a patient with inflammatory back pain as suffering from spondyloarthritis.
Gazeau P; Cornec D; Timsit MA; Dougados M; Saraux A
Joint Bone Spine; 2018 Jan; 85(1):85-91. PubMed ID: 28214597
[TBL] [Abstract][Full Text] [Related]
24. Disease activity is longitudinally related to sacroiliac inflammation on MRI in male patients with axial spondyloarthritis: 2-years of the DESIR cohort.
Navarro-Compán V; Ramiro S; Landewé R; Dougados M; Miceli-Richard C; Richette P; van der Heijde D
Ann Rheum Dis; 2016 May; 75(5):874-8. PubMed ID: 26403689
[TBL] [Abstract][Full Text] [Related]
25. 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis.
van der Heijde D; Sieper J; Maksymowych WP; Dougados M; Burgos-Vargas R; Landewé R; Rudwaleit M; Braun J;
Ann Rheum Dis; 2011 Jun; 70(6):905-8. PubMed ID: 21540200
[TBL] [Abstract][Full Text] [Related]
26. A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritis.
Sieper J; van der Heijde D; Dougados M; Maksymowych WP; Scott BB; Boice JA; Berd Y; Bergman G; Curtis S; Tzontcheva A; Huyck S; Weng HH
Arthritis Rheumatol; 2015 Oct; 67(10):2702-12. PubMed ID: 26139307
[TBL] [Abstract][Full Text] [Related]
27. Brief Report: Six-Week Treatment of Axial Spondyloarthritis Patients With an Optimal Dose of Nonsteroidal Antiinflammatory Drugs: Early Response to Treatment in Signal Intensity on Magnetic Resonance Imaging of the Sacroiliac Joints.
Varkas G; Jans L; Cypers H; Van Praet L; Carron P; Elewaut D; Van den Bosch F
Arthritis Rheumatol; 2016 Mar; 68(3):672-8. PubMed ID: 26473982
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the validity of the different arms of the ASAS set of criteria for axial spondyloarthritis and description of the different imaging abnormalities suggestive of spondyloarthritis: data from the DESIR cohort.
Moltó A; Paternotte S; van der Heijde D; Claudepierre P; Rudwaleit M; Dougados M
Ann Rheum Dis; 2015 Apr; 74(4):746-51. PubMed ID: 24389295
[TBL] [Abstract][Full Text] [Related]
29. Predictors of Loss of Remission and Disease Flares in Patients with Axial Spondyloarthritis Receiving Antitumor Necrosis Factor Treatment: A Retrospective Study.
Lubrano E; Massimo Perrotta F; Manara M; D'Angelo S; Addimanda O; Ramonda R; Punzi L; Olivieri I; Salvarani C; Marchesoni A
J Rheumatol; 2016 Aug; 43(8):1541-6. PubMed ID: 27252428
[TBL] [Abstract][Full Text] [Related]
30. The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis.
Nissen MJ; Ciurea A; Bernhard J; Tamborrini G; Mueller R; Weiss B; Toniolo M; Exer P; Gabay C; Finckh A;
Arthritis Rheumatol; 2016 Sep; 68(9):2141-50. PubMed ID: 27015429
[TBL] [Abstract][Full Text] [Related]
31. Effect of enthesitis on 1505 Brazilian patients with spondyloarthritis.
Carneiro S; Bortoluzzo A; Gonçalves C; Silva JA; Ximenes AC; Bértolo M; Ribeiro SL; Keiserman M; Skare T; Menin R; Azevedo V; Vieira W; Albuquerque E; Bianchi W; Bonfiglioli R; Campanholo C; Carvalho HM; Costa Id; Duarte A; Kohem C; Leite N; Lima SA; Meirelles ES; Pereira IA; Pinheiro MM; Polito E; Resende GG; Rocha FA; Santiago MB; Sauma Mde F; Valim V; Sampaio-Barros PD
J Rheumatol; 2013 Oct; 40(10):1719-25. PubMed ID: 23858049
[TBL] [Abstract][Full Text] [Related]
32. The classification and diagnostic criteria of ankylosing spondylitis.
Raychaudhuri SP; Deodhar A
J Autoimmun; 2014; 48-49():128-33. PubMed ID: 24534717
[TBL] [Abstract][Full Text] [Related]
33. An epidemiological study of the prevalence rate of inflammatory back pain and axial spondyloarthritis in a university in the south of China.
Tong F; Lv Q; Li A; Fang L; Luo Z; Feng J; Gu J; Lin Z
Clin Rheumatol; 2018 Nov; 37(11):3087-3091. PubMed ID: 29974281
[TBL] [Abstract][Full Text] [Related]
34. Factors Associated With Treatment Pathways in Early Axial Spondyloarthritis: A Multistate Analysis of the 10-Year Follow-Up of the DESIR Cohort.
Portier E; Chevret S; Walter-Petrich A; Ruyssen-Witrand A; Dougados M; Moltó A
J Rheumatol; 2024 Apr; 51(4):368-377. PubMed ID: 38359943
[TBL] [Abstract][Full Text] [Related]
35. Assessment of SpondyloArthritis International Society criteria for axial spondyloarthritis in chronic back pain patients with a high prevalence of HLA-B27.
Bakland G; Alsing R; Singh K; Nossent JC
Arthritis Care Res (Hoboken); 2013 Mar; 65(3):448-53. PubMed ID: 22833469
[TBL] [Abstract][Full Text] [Related]
36. Referral patterns, diagnosis, and disease management of patients with axial spondyloarthritis: results of an international survey.
van der Heijde D; Sieper J; Elewaut D; Deodhar A; Pangan AL; Dorr AP
J Clin Rheumatol; 2014 Dec; 20(8):411-7. PubMed ID: 25417676
[TBL] [Abstract][Full Text] [Related]
37. Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy.
Tse SM; Burgos-Vargas R; Laxer RM
Arthritis Rheum; 2005 Jul; 52(7):2103-8. PubMed ID: 15986366
[TBL] [Abstract][Full Text] [Related]
38. Body weight, gender and response to TNF-α blockers in axial spondyloarthritis.
Gremese E; Bernardi S; Bonazza S; Nowik M; Peluso G; Massara A; Tolusso B; Messuti L; Miceli MC; Zoli A; Trotta F; Govoni M; Ferraccioli G
Rheumatology (Oxford); 2014 May; 53(5):875-81. PubMed ID: 24407233
[TBL] [Abstract][Full Text] [Related]
39. Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis.
Maksymowych WP; Inman RD; Gladman D; Thomson G; Stone M; Karsh J; Russell AS;
J Rheumatol; 2003 Jun; 30(6):1356-63. PubMed ID: 12784417
[TBL] [Abstract][Full Text] [Related]
40. Is a positive family history of spondyloarthritis relevant for diagnosing axial spondyloarthritis once HLA-B27 status is known?
van Lunteren M; van der Heijde D; Sepriano A; Berg IJ; Dougados M; Gossec L; Jacobsson L; Ramonda R; Rudwaleit M; Sieper J; Landewé R; van Gaalen FA
Rheumatology (Oxford); 2019 Sep; 58(9):1649-1654. PubMed ID: 30938446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
